AstraZeneca seeks emergency use authorization of covid prophylaxis drug in U.S

On Tuesday, drugmaker AstraZeneca announced that it has requested an emergency use authorization grant from the U.S. Food and Drug Administration (FDA) for its Covid-19 prophylaxis drug.

This comes a month after the antibody cocktail was proven to be effective in the prevention of Covid symptoms among people highly at risk to be infected who received the drug prior to exposure, according to Forbes.

According to the company in a press release, its Phase III trial featuring over 5,000 participants revealed that the antibody cocktail was 77% effective in people who received the drug as a preventive measure by reducing the risk of developing Covid-19 symptoms.

Related posts

Australia to buy 300,000 Merck’s Covid-19 capsule as cases hit record high

WHO: Air pollution increases risk of severe COVID-19 infection

The drug was developed as an antibody treatment that uses lab-made antibodies that can stay for months in the recipient’s body and protect them against infection.

It is however, important to note that the antibody treatments are not vaccines. Unlike the antibody treatments, vaccine which helps a recipient’s immune system build its own antibodies and infection-fighting cells against the virus.

According to Astrazeneca, the antibody treatment is effective in protecting people who may not develop a robust immune response to Covid-19 vaccines.

In addition, the company noted that trials performed in Vitro, I.e test tubes showed that the drug was able to neutralize emergent Covid variants, including delta and mu, adding that supply agreements for the antibody cocktail are in the works with the United States and other governments.

As stated by Astrazeneca’s chief of research and development, Mene Pangalos: “Vulnerable populations such as the immunocompromised often aren’t able to mount a protective response following vaccination and continue to be at risk of developing COVID-19. With this first global regulatory filing, we are one step closer to providing an additional option to help protect against COVID-19 alongside vaccines.”

Recall that, in June 2021, a trial of AstraZeneca’s antibody therapy among patients exposed to the virus failed to prevent symptoms. The effectiveness of the drug among people already exposed to the virus was only 33%, including exposed individuals who tested negative.

Related

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Who is Ella Craig? The life story of Daniel Craig’s daughter thumbnail

Who is Ella Craig? The life story of Daniel Craig’s daughter

Ella Craig is a British actress and celebrity daughter. She is widely recognised as the daughter of Daniel Wroughton Craig, popularly known as James Bond. Her father is a prominent English actor with over 70 acting credits. He is best known for playing James Bond in several films such as Skyfall, No Time to Die
Read More
Márta Mészáros will receive the Lifetime Achievement Award of the European Film Academy this year thumbnail

Márta Mészáros will receive the Lifetime Achievement Award of the European Film Academy this year

A világ filmművészetéhez való egyedülálló hozzájárulása elismeréseként Mészáros Márta kapja az Európai Filmakadémia életműdíját a 34. Európai Filmdíj átadó ünnepségén, december 11-én Berlinben. A MUBI nemzetközi streaming platform a magyar rendező életművének fontos filmjeivel tiszteleg a rendező előtt. Bátor és innovatív filmjein keresztül Mészáros Márta elkötelezte magát a női életek bemutatása mellett, hangot adva a…
Read More
The author of the Facebook leaks revealed her identity.  He accuses the company of putting profits before safety thumbnail

The author of the Facebook leaks revealed her identity. He accuses the company of putting profits before safety

Była analityczka Facebooka Frances Haugen skopiowała dokumenty ujawniające badania na temat tego, w jaki sposób platforma przyczynia się do zwiększenia polaryzacji w społeczeństwie oraz jak korzystanie z Instagrama, który należy do Facebooka, negatywnie wpływa na psychikę nastolatków. Kobieta ujawniła swoją tożsamość na antenie CBS. Frances  Haugen skopiowała tysiące stron dokumentów firmy, ujawniając badania na temat…
Read More
Recipe for Chinese supersonic missiles.  Japan is developing electromagnetic cannons thumbnail

Recipe for Chinese supersonic missiles. Japan is developing electromagnetic cannons

Agentura pro akvizici, technologii a logistiku japonského ministerstva obrany začala zkoumat technologii, která by umožnila vytvoření účinného systému obrany proti hypersonickým zbraním. V rozpočtu na fiskální rok 2022 byla na vývoj vyčleněna částka 6,5 miliardy jenů (1,2 miliardy korun). Čínští vědci nedávno hrdě oznámili, že se jim povedlo dosáhnout „série průlomů v klíčové technologii“ infračerveného…
Read More
Djokovic's saga in Melbourne - the second topic in terms of representation in news programs thumbnail

Djokovic's saga in Melbourne – the second topic in terms of representation in news programs

Podaci Agencije za praćenje i analizu medijskog sadržaja „Kliping“ pokazuju da su tri  najzastupljenije teme u najavama vesti centralnih informativnih emisija televizija sa nacionalnom frekvencijom (RTS 1, TV B92, TV Prva, TV Pink  i Happy TV) i regionalne kablovske TV N1 – korona virus u Srbiji (12,88%), saga sa odlaskom Novaka Đokovića u Australiju  (10,23%)…
Read More
Lisa Wilkinson called out by top doctor after calling Australia's Covid response a 'bin fire' thumbnail

Lisa Wilkinson called out by top doctor after calling Australia’s Covid response a ‘bin fire’

Australian TV host Lisa Wilkinson has been slammed for comparing Australia's response to the latest Covid-19 outbreak to a 'bin fire'. On Sunday, Wilkinson said Australia's 'bin fire' handling of the Omicron crisis is what prompted Jacinda Ardern to plunge all of New Zealand into Covid 'red alert' and postpone her own wedding. Among the new rules is that household…
Read More
Index Of News
Total
0
Share